Methodology

All entries for: argenx BV

August 20, 2025

argenx BV

Orphan Drug Designation

FDA orphan drug designation: treatment of idiopathic inflammatory myopathy

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top